+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pregabalin"

From
TARLIGE Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

TARLIGE Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Diabetic Neuropathic Pain - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Postherpetic Neuralgia - Pipeline Insight, 2026 - Product Thumbnail Image

Postherpetic Neuralgia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
From
Chemotherapy Induced Pain Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Chemotherapy Induced Pain Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Pain Management Drugs Market Overview, 2025-2030 - Product Thumbnail Image

Pain Management Drugs Market Overview, 2025-2030

  • Report
  • November 2025
  • 138 Pages
  • Global
From
Europe Pain Management Drugs Market Outlook, 2030 - Product Thumbnail Image

Europe Pain Management Drugs Market Outlook, 2030

  • Report
  • November 2025
  • 114 Pages
  • Europe
From
From
Trigeminal Neuralgia- Pipeline Insight, 2025 - Product Thumbnail Image

Trigeminal Neuralgia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peripheral Neuropathic Pain-Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain-Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator

Pregabalin is a drug used to treat a variety of conditions related to the central nervous system, including epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It is a gamma-aminobutyric acid (GABA) analog that works by binding to certain calcium channels in the brain, reducing the release of neurotransmitters that can cause pain and anxiety. Pregabalin is available in both oral and injectable forms, and is often prescribed in combination with other medications. Pregabalin is a relatively new drug, having been approved by the US Food and Drug Administration in 2004. Since then, it has become a popular treatment option for many conditions related to the central nervous system. It is generally well-tolerated and has fewer side effects than other drugs used to treat similar conditions. Some of the companies in the Pregabalin market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more